Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Top Cited Papers
- 18 May 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 12 (6), 575-582
- https://doi.org/10.1016/s1470-2045(11)70097-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Preoperative High-resolution Magnetic Resonance Imaging Can Identify Good Prognosis Stage I, II, and III Rectal Cancer Best Managed by Surgery AloneAnnals of Surgery, 2011
- Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal CancerAnnals of Surgery, 2011
- Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancerBritish Journal of Surgery, 2010
- Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trialThe Lancet, 2009
- Caspase-3 Activity Predicts Local Recurrence in Rectal CancerClinical Cancer Research, 2007
- Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcomeEuropean Journal of Surgical Oncology, 2005
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapyRadiotherapy and Oncology, 2004
- The Stockholm II trial on preoperative radiotherapy in rectal carcinomaCancer, 2001
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Mesorectal excision for rectal cancerThe Lancet, 1993